245 related articles for article (PubMed ID: 31021423)
1. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculosis drugs: Two case reports and a review of the literature.
Coster A; Aerts O; Herman A; Marot L; Horst N; Kenyon C; Vlieghe E; Hainaut P; Baeck M
Contact Dermatitis; 2019 Nov; 81(5):325-331. PubMed ID: 31021423
[TBL] [Abstract][Full Text] [Related]
2. Antituberculosis Drug-Associated DRESS: A Case Series.
Allouchery M; Logerot S; Cottin J; Pralong P; Villier C; Ben Saïd B;
J Allergy Clin Immunol Pract; 2018; 6(4):1373-1380. PubMed ID: 29274824
[TBL] [Abstract][Full Text] [Related]
3. Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review.
de Groot AC
Contact Dermatitis; 2022 Jun; 86(6):443-479. PubMed ID: 35233782
[TBL] [Abstract][Full Text] [Related]
4. Positive Allergy Study (Intradermal, Patch, and Lymphocyte Transformation Tests) in a Case of Isoniazid-Induced DRESS.
Arruti N; Villarreal O; Bernedo N; Audicana MT; Velasco M; Uriel O; Martinez A; Bellón T
J Investig Allergol Clin Immunol; 2016; 26(2):119-20. PubMed ID: 27164631
[No Abstract] [Full Text] [Related]
5. Drug-specific CD4
Ye YM; Hur GY; Kim SH; Ban GY; Jee YK; Naisbitt DJ; Park HS; Kim SH
Br J Dermatol; 2017 Feb; 176(2):378-386. PubMed ID: 27373553
[TBL] [Abstract][Full Text] [Related]
6. Multiple Drug Hypersensitivity Syndrome to Antituberculosis Drugs: A Case Report.
Carneiro-Leão L; Gomes I; Freitas C; Costa E Silva M; Viseu R; Cernadas J
J Investig Allergol Clin Immunol; 2020; 30(1):70-71. PubMed ID: 31530510
[No Abstract] [Full Text] [Related]
7. [DRESS syndrome secondary to antituberculosis drugs: about a case].
Jridi S; Azzeddine R; Bourkadi JE
Pan Afr Med J; 2017; 27():37. PubMed ID: 28761613
[TBL] [Abstract][Full Text] [Related]
8. Difficult clinical management of antituberculosis DRESS syndrome complicated by MRSA infection: A case report.
Wang L; Li LF
Medicine (Baltimore); 2017 Mar; 96(11):e6346. PubMed ID: 28296768
[TBL] [Abstract][Full Text] [Related]
9. DRESS syndrome and acute generalized exanthematous pustulosis induced by antituberculosis medications and moxifloxacin: case report
.
Kim H; Bang ES; Lim SK; Lee JM
Int J Clin Pharmacol Ther; 2016 Oct; 54(10):808-15. PubMed ID: 27443659
[TBL] [Abstract][Full Text] [Related]
10. [The "DRESS" syndrome in antituberculosis drugs].
Bopaka RG; El Khattabi W; Afif H; Aichane A; Bouayad Z
Rev Pneumol Clin; 2014 Jun; 70(3):185-8. PubMed ID: 24646784
[TBL] [Abstract][Full Text] [Related]
11. [Concomitant Drug Reaction with Eosinophilia and Systemic Symptom Syndrome from Ethambutol and Autoimmune Hepatitis from Isoniazid].
Choi JH; Heo NY; Park SH; Park CS; Jo KM; Kim WG; Nam KH
Korean J Gastroenterol; 2016 May; 67(5):267-271. PubMed ID: 27206439
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study.
Jung HY; Park S; Shin B; Lee JH; Lee SJ; Lee MK; Lee WY; Yong SJ; Kim SH
Allergy Asthma Immunol Res; 2019 Jan; 11(1):90-103. PubMed ID: 30479080
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
Lee JY; Lee SY; Hahm JE; Ha JW; Kim CW; Kim SS
Int J Dermatol; 2017 Sep; 56(9):944-951. PubMed ID: 28718873
[TBL] [Abstract][Full Text] [Related]
14. Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.
Sharma SK; Singla R; Sarda P; Mohan A; Makharia G; Jayaswal A; Sreenivas V; Singh S
Clin Infect Dis; 2010 Mar; 50(6):833-9. PubMed ID: 20156055
[TBL] [Abstract][Full Text] [Related]
15. Antituberculosis-Drugs Induced DRESS: A Multidrug Hypersensitivity or Drug Hypersensitivity Relapse? A Case Report.
Mansour K; Chadli Z; Ben Fadhel N; Ben Fredj N; Ben Romdhane H; Chaabane A; Toumi A; Aouam K
Hosp Pharm; 2024 Feb; 59(1):10-14. PubMed ID: 38223863
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting.
Porter M; Choshi P; Pedretti S; Chimbetete T; Smith R; Meintjes G; Phillips E; Lehloenya R; Peter J
J Invest Dermatol; 2022 Nov; 142(11):2920-2928.e5. PubMed ID: 35659939
[TBL] [Abstract][Full Text] [Related]
17. Adverse reactions to antituberculosis drugs presenting as DRESS syndrome and acute liver failure.
Carlin Ronquillo A; Alvizuri Gómez C; García-Encinas C
Rev Gastroenterol Peru; 2022; 42(2):136-138. PubMed ID: 36513361
[TBL] [Abstract][Full Text] [Related]
18. Antituberculosis drug-induced non-blistering systemic severe reactions: A 10-year (2012-2022) literature review.
Rizzi A; Nucera E; Urbani S; Longhino D; Lohmeyer FM; Gambassi G; Krishnamra N; Gammeri L; Gangemi S; Inchingolo R
Asian Pac J Allergy Immunol; 2023 Dec; 41(4):273-291. PubMed ID: 37874314
[TBL] [Abstract][Full Text] [Related]
19. [DRESS syndrome induced by anti-TB drugs].
Pavón-Romero GF; Parra-Vargas MI; Rosas-Fernández R; Ramírez-Jiménez F; Gutiérrez-Quiroz KV; Terán LM
Rev Alerg Mex; 2023 Jun; 70(2):55-63. PubMed ID: 37566768
[TBL] [Abstract][Full Text] [Related]
20. Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results.
Özkaya E
Cutis; 2013 Sep; 92(3):121-4. PubMed ID: 24153138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
